186 related articles for article (PubMed ID: 25318079)
1. Non-classical MHC-I human leukocyte antigen (HLA-G) in hepatotropic viral infections and in hepatocellular carcinoma.
Catamo E; Zupin L; Crovella S; Celsi F; Segat L
Hum Immunol; 2014 Dec; 75(12):1225-31. PubMed ID: 25318079
[TBL] [Abstract][Full Text] [Related]
2. HLA-G genetic variants and hepatocellular carcinoma: a meta-analysis.
Coelho AV; Moura RR; Crovella S; Celsi F
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706615
[TBL] [Abstract][Full Text] [Related]
3. HLA-A, B, C, DR and DQ expression and hepatocellular carcinoma: study of 205 Italian subjects.
Ricci G; Colombo C; Ghiazza B; Porta C; Moroni M; Illeni MT
Cancer Lett; 1995 Nov; 98(1):121-5. PubMed ID: 8529200
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
[TBL] [Abstract][Full Text] [Related]
5. HLA-G susceptibility to hepatitis B infection and related hepatocellular carcinoma in the Japanese population.
Okumura T; Joshita S; Yamazaki T; Iwadare T; Wakabayashi SI; Kobayashi H; Yamashita Y; Sugiura A; Kimura T; Ota M; Umemura T
Hum Immunol; 2023 Aug; 84(8):401-407. PubMed ID: 37271588
[TBL] [Abstract][Full Text] [Related]
6. RNA interfering targeting human leukocyte antigen-G enhanced immune surveillance mediated by the natural killer cells on hepatocellular carcinoma.
Zeng XC; Zhang T; Huang DH; Wang GY; Chen W; Li H; Zhang J; Fang TL; Zhang Q; Chen GH
Ann Clin Lab Sci; 2013; 43(2):135-44. PubMed ID: 23694787
[TBL] [Abstract][Full Text] [Related]
7. Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.
Park Y; Park Y; Lim HS; Kim YS; Hong DJ; Kim HS
Tissue Antigens; 2012 Feb; 79(2):97-103. PubMed ID: 22136460
[TBL] [Abstract][Full Text] [Related]
8. Association of HLA-G 3' UTR 14-bp insertion/deletion polymorphism with hepatocellular carcinoma susceptibility in a Chinese population.
Jiang Y; Chen S; Jia S; Zhu Z; Gao X; Dong D; Gao Y
DNA Cell Biol; 2011 Dec; 30(12):1027-32. PubMed ID: 21612396
[TBL] [Abstract][Full Text] [Related]
9. Association between HLA-G 14-bp insertion/deletion polymorphism and hepatocellular carcinoma in Korean patients with chronic hepatitis B viral infection.
Kim SK; Chung JH; Jeon JW; Park JJ; Cha JM; Joo KR; Lee JI; Shin HP
Hepatogastroenterology; 2013 Jun; 60(124):796-8. PubMed ID: 23732778
[TBL] [Abstract][Full Text] [Related]
10. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
Shiratori Y; Shiina S; Zhang PY; Ohno E; Okudaira T; Payawal DA; Ono-Nita SK; Imamura M; Kato N; Omata M
Cancer; 1997 Dec; 80(11):2060-7. PubMed ID: 9392327
[TBL] [Abstract][Full Text] [Related]
11. HLA-class II alleles in Egyptian patients with hepatocellular carcinoma.
El-Chennawi FA; Auf FA; Metwally SS; Mosaad YM; El-Wahab MA; Tawhid ZE
Immunol Invest; 2008; 37(7):661-74. PubMed ID: 18821214
[TBL] [Abstract][Full Text] [Related]
12. The immunosuppressive molecule HLA-G and its clinical implications.
González A; Rebmann V; LeMaoult J; Horn PA; Carosella ED; Alegre E
Crit Rev Clin Lab Sci; 2012; 49(3):63-84. PubMed ID: 22537084
[TBL] [Abstract][Full Text] [Related]
13. Biology of the immunomodulatory molecule HLA-G in human liver diseases.
Amiot L; Vu N; Samson M
J Hepatol; 2015 Jun; 62(6):1430-7. PubMed ID: 25772038
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus down-regulates expressions of MHC class I molecules on hepatoplastoma cell line.
Chen Y; Cheng M; Tian Z
Cell Mol Immunol; 2006 Oct; 3(5):373-8. PubMed ID: 17092435
[TBL] [Abstract][Full Text] [Related]
15. Histocompatibility antigens in patients with hepatocellular carcinoma and their relationship to chronic hepatitis B virus infection in these patients.
Kew MC; Gear AJ; Baumgarten I; Dusheiko GM; Maier G
Gastroenterology; 1979 Sep; 77(3):537-9. PubMed ID: 222645
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus-related hepatocellular carcinoma and B-cell lymphoma patients show a different profile of major histocompatibility complex class II alleles.
De Re V; Caggiari L; Talamini R; Crovatto M; De Vita S; Mazzaro C; Cannizzaro R; Dolcetti R; Boiocchi M
Hum Immunol; 2004 Nov; 65(11):1397-404. PubMed ID: 15556690
[TBL] [Abstract][Full Text] [Related]
17. The 14bp-deletion allele in the HLA-G gene confers susceptibility to the development of hepatocellular carcinoma in the Brazilian population.
Teixeira AC; Mendes-Junior CT; Souza FF; Marano LA; Deghaide NH; Ferreira SC; Mente ED; Sankarankutty AK; Elias-Junior J; Castro-e-Silva O; Donadi EA; Martinelli AL
Tissue Antigens; 2013 Jun; 81(6):408-13. PubMed ID: 23506091
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of anti-HCV in sera of patients with hepatocellular carcinoma].
Yu ZY
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):44-6. PubMed ID: 7687532
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of soluble and membrane-bound human leukocyte antigen G expression is primarily observed in the milder histopathological stages of chronic hepatitis C virus infection.
de Oliveira Crispim JC; Silva TG; Souto FJ; Souza FF; Bassi CL; Soares CP; Zucoloto S; Moreau P; Martinelli Ade L; Donadi EA
Hum Immunol; 2012 Mar; 73(3):258-62. PubMed ID: 22178697
[TBL] [Abstract][Full Text] [Related]
20. Non-classical MHC-Ι genes in chronic hepatitis B and hepatocellular carcinoma.
Zhang J; Pan L; Chen L; Feng X; Zhou L; Zheng S
Immunogenetics; 2012 Mar; 64(3):251-8. PubMed ID: 22015712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
